Advertisement

Suppliers' News

Pancosma confirms efficacy of new product to support WFD-infected shrimp

Pancosma has completed a trial confirming the efficacy of its new product to support shrimp performance when infected with White Feces Disease (WFD). The latest XTRACT® product from Pancosma consists in a micro encapsulated allicin-based additive. In the recent trial performed in Ho Chi Minh City, Vietnam, WFD-infected shrimp who received feed supplemented with XTRACT® showed a significant reduction of the disease signs.
August 9, 2018

Pancosma has completed a trial confirming the efficacy of its new product to support shrimp performance when infected with White Feces Disease (WFD).

The latest XTRACT® product from Pancosma consists in a microencapsulated additive based on an active ingredient inspired from nature: garlic. Garlic has been used for ages in shrimp production but what makes Pancosma active stands apart is the fact that the product is stabilized and standardized, unlike the typical allicin based-additive traditionally found on the worldwide market.

WFD, known to severely affect shrimp intestinal epithelium and digestive organs, creates substantial decrease in growth rate (BWG), feed intake and an increase in Feed Conversion Ratio (FCR).

In a recent trial performed in Ho Chi Minh City, Vietnam, WFD-infected shrimp who received feed supplemented with XTRACT® showed a significant reduction of the disease signs. Improvements in performance (BWG & FCR) and higher survival rate (+ 10%) demonstrated that XTRACT® has a protective effect against this infection.